The global antifungal drugs market was valued at approximately USD 15.8 billion in 2023 and is forecasted to expand at a compound annual growth rate (CAGR) of 3.8% from 2024 to 2030. The increasing prevalence of fungal infections, such as aspergillosis and candidiasis, is a primary factor driving market growth. Fungal infections can range from systemic to superficial and include ailments...